141 related articles for article (PubMed ID: 1679658)
1. The role of histamine in the acute inflammatory responses to intradermal platelet activating factor.
Sciberras DG; Jordan S; Gill D; Baber NS; James I
Br J Clin Pharmacol; 1991 Jul; 32(1):85-90. PubMed ID: 1679658
[TBL] [Abstract][Full Text] [Related]
2. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
Shall L; Newcombe RG; Lush M; Marks R
Acta Derm Venereol; 1991; 71(3):199-204. PubMed ID: 1678220
[TBL] [Abstract][Full Text] [Related]
4. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects.
Jenks PJ; Kavanagh GM; Brooks J; Bradfield JW; Archer CB
Clin Exp Dermatol; 1999 Mar; 24(2):112-7. PubMed ID: 10233666
[TBL] [Abstract][Full Text] [Related]
5. Wheal-and-flare responses to intradermally injected adenosine 5'-monophosphate, hypertonic saline, and histamine: comparison of atopic and nonatopic subjects.
Djukanovic R; Finnerty JP; Holgate ST
J Allergy Clin Immunol; 1989 Sep; 84(3):373-8. PubMed ID: 2506263
[TBL] [Abstract][Full Text] [Related]
6. The effects of astemizole on histamine-induced weal and flare.
Bateman DN; Chapman PH; Rawlins MD
Eur J Clin Pharmacol; 1983; 25(4):547-51. PubMed ID: 6140168
[TBL] [Abstract][Full Text] [Related]
7. Terfenadine effect on the bronchoconstriction, dermal response, and leukopenia induced by platelet-activating factor.
Hopp RJ; Townley RG; Agrawal DK; Bewtra AK
Chest; 1991 Oct; 100(4):994-8. PubMed ID: 1914619
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive instrumental techniques to detect terfenadine and temelastine induced suppression of histamine weals in man.
Shall L; Marks R
Br J Clin Pharmacol; 1987 Oct; 24(4):409-13. PubMed ID: 2891368
[TBL] [Abstract][Full Text] [Related]
9. Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects.
Juhlin L; Pihl-Lundin I
Acta Derm Venereol; 1992; 72(3):197-200. PubMed ID: 1357858
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of inhibition of wheal response to histamine by multiple doses of terfenadine.
Ryan WM
Ann Allergy; 1989 Dec; 63(6 Pt 2):609-11. PubMed ID: 2574553
[TBL] [Abstract][Full Text] [Related]
11. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
12. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the duration of action of terfenadine on histamine induced weals.
Shall L; Newcombe RG; Marks R
Br J Dermatol; 1988 Oct; 119(4):525-31. PubMed ID: 3142511
[TBL] [Abstract][Full Text] [Related]
14. The importance of bradykinin and histamine in the skin response to antigen.
Warren JB; Newman CM; Pixley FJ; Fuller RW; Dollery CT
Br J Clin Pharmacol; 1988 Dec; 26(6):803-5. PubMed ID: 2853961
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation.
Sciberras DG; Goldenberg MM; Bolognese JA; James I; Baber NS
Br J Clin Pharmacol; 1987 Dec; 24(6):753-61. PubMed ID: 2449904
[TBL] [Abstract][Full Text] [Related]
16. The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin.
Kavanagh GM; Sabroe RA; Greaves MW; Archer CB
Br J Dermatol; 1998 Apr; 138(4):622-6. PubMed ID: 9640366
[TBL] [Abstract][Full Text] [Related]
17. Effect of azelastine and ketotifen on the bronchial and skin responses to platelet-activating factor in humans.
Lai CK; Ollier S; Lau CK; Holgate ST
Clin Exp Allergy; 1991 Jul; 21(4):489-96. PubMed ID: 1680533
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Van Neste D; Rihoux JP
Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
[TBL] [Abstract][Full Text] [Related]
19. Effect of terbutaline, a beta 2-adrenergic receptor stimulating compound, on cutaneous reponses to histamine, allergen, compound 48/80, and trypsin.
Grönneberg R; Strandberg K; Hägermark O
Allergy; 1979 Oct; 34(5):303-9. PubMed ID: 44669
[TBL] [Abstract][Full Text] [Related]
20. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.
Archer CB; MacDonald DM; Morley J; Page CP; Paul W; Sanjar S
Br J Pharmacol; 1985 May; 85(1):109-13. PubMed ID: 2862936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
